It could also help it keep pace with rival drugs in the SGLT2 inhibitor class as competition gets more intense. Last year, Jardiance achieved encouraging results in the EMPA-REG OUTCOME trial ...

Jardiance was the trail blazer in this class, becoming the first diabetes drug to show a dual effect of reducing risk of nonfatal stroke, nonfatal heart attacks and cardiovascular death in high ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...